These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 32812775)

  • 1. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal-jejunal bypass surgery suppresses hepatic de novo lipogenesis and alleviates liver fat accumulation in a diabetic rat model.
    Han H; Hu C; Wang L; Zhang G; Liu S; Li F; Sun D; Hu S
    Obes Surg; 2014 Dec; 24(12):2152-60. PubMed ID: 24898720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal jejunal bypass attenuates non-alcoholic fatty liver disease in western diet-obese rats.
    Ebertz CE; Bonfleur ML; Bertasso IM; Mendes MC; Lubaczeuski C; Araujo AC; Paes AM; de Amorim EM; Balbo SL
    Acta Cir Bras; 2014 Sep; 29(9):609-14. PubMed ID: 25252208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic
    Bertasso IM; Pietrobon CB; Ribeiro RA; Soares GM; Oliveira JC; Alegre-Maller ACP; Boschero AC; Araújo ACF; Guimarães ATB; Bonfleur ML; Balbo SL
    J Dev Orig Health Dis; 2022 Apr; 13(2):263-273. PubMed ID: 33998431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal-jejunal bypass maintains hepatic S-adenosylmethionine/S-homocysteine ratio in diet-induced obese rats.
    Kim M; Rho Y; Park R; Jung J; Hwang GS; Seo YK; Seo JH; Heo Y; Ha TK; Ha E
    Surg Obes Relat Dis; 2021 Jul; 17(7):1359-1368. PubMed ID: 33753007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats.
    Cantelli KR; Soares GM; Ribeiro RA; Balbo SL; Lubaczeuski C; Boschero AC; Araújo AC; Bonfleur ML
    Braz J Med Biol Res; 2017 Mar; 50(5):e5858. PubMed ID: 28380195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats.
    Sun D; Wang K; Yan Z; Zhang G; Liu S; Liu F; Hu C; Hu S
    Obes Surg; 2013 Nov; 23(11):1734-42. PubMed ID: 23700236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats.
    Han HF; Liu SZ; Zhang X; Wei M; Huang X; Yu WB
    World J Gastroenterol; 2022 Aug; 28(31):4338-4350. PubMed ID: 36159018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress.
    Mosinski JD; Pagadala MR; Mulya A; Huang H; Dan O; Shimizu H; Batayyah E; Pai RK; Schauer PR; Brethauer SA; Kirwan JP
    Acta Physiol (Oxf); 2016 Jun; 217(2):141-51. PubMed ID: 26663034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver steatosis in hypothalamic obese rats improves after duodeno-jejunal bypass by reduction in de novo lipogenesis pathway.
    Soares GM; Cantelli KR; Balbo SL; Ribeiro RA; Alegre-Maller ACP; Barbosa-Sampaio HC; Boschero AC; Araújo ACF; Bonfleur ML
    Life Sci; 2017 Nov; 188():68-75. PubMed ID: 28866102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic benefits of gastric bypass surgery in the mouse: The role of fecal losses.
    Barataud A; Vily-Petit J; Goncalves D; Zitoun C; Duchampt A; Philippe E; Gautier-Stein A; Mithieux G
    Mol Metab; 2020 Jan; 31():14-23. PubMed ID: 31918916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device.
    Casella-Mariolo J; Castagneto-Gissey L; Angelini G; Zoli A; Marini P; Bornstein SR; Pournaras DJ; Rubino F; le Roux CW; Mingrone G; Casella G
    EBioMedicine; 2019 Aug; 46():452-462. PubMed ID: 31401193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH.
    Tsuchiya T; Naitoh T; Nagao M; Tanaka N; Watanabe K; Imoto H; Miyachi T; Motoi F; Unno M
    Obes Surg; 2018 Jun; 28(6):1643-1652. PubMed ID: 29235014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
    Pereira RM; Rodrigues KCDC; Anaruma CP; Sant'Ana MR; de Campos TDP; Gaspar RS; Canciglieri RDS; de Melo DG; Mekary RA; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
    J Endocrinol; 2019 Apr; 241(1):59-70. PubMed ID: 30878016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass.
    Han H; Wang L; Du H; Jiang J; Hu C; Zhang G; Liu S; Zhang X; Liu T; Hu S
    Obes Surg; 2015 Oct; 25(10):1802-9. PubMed ID: 25726319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents.
    Kindel TL; Martins PJ; Yoder SM; Jandacek RJ; Seeley RJ; D'Alessio DA; Obici S; Tso P
    Obesity (Silver Spring); 2011 Feb; 19(2):380-7. PubMed ID: 21030948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal-jejunal bypass surgery enhances glucose tolerance and beta-cell function in Western diet obese rats.
    Araujo AC; Bonfleur ML; Balbo SL; Ribeiro RA; de Freitas AC
    Obes Surg; 2012 May; 22(5):819-26. PubMed ID: 22411572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.